Plain-English translation of NCT07086820 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether children and teenagers exposed to tuberculosis in their own homes should start preventive treatment right away, rather than waiting for test results. Normally, doctors wait to see if a child tests positive for TB infection before starting treatment. This study compares that standard approach to starting treatment immediately for all exposed children, using isoniazid and rifapentine as preventive medications.
TB infection can be hard to detect in the early weeks after exposure because it takes time for the body to show it has the infection. Recent research suggests that starting this medication during that early window period—before infection is confirmed—might actually prevent children from catching TB in the first place, which could be a more effective way to stop TB from spreading.
You likely qualify if…
You likely don't qualify if…
If you join, you will either receive preventive medication immediately (the new approach being tested) or only if your TB test comes back positive (the standard approach). You'll take the medication by mouth for a set period and have follow-up visits to check how you're doing and make sure the treatment is working well. The study will track whether you develop TB infection over time.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Chile